ASCO has endorsed Barbara McAneny, MD, FASCO, MACP, in her campaign for President-elect of the American Medical Association (AMA). Dr. McAneny, a medical oncology/hematologist from New Mexico, would be the first oncologist elected to serve as AMA President.
Dr. McAneny is an active ASCO volunteer, previously serving on the ASCO Board of Directors (2005 – 2008) and as a liaison to the AMA House of Delegates (2002 – 2013). She has also long been active in the AMA, and is past chair and current member of the AMA Board of Trustees.
A nationally recognized leader in promoting high-quality, high-value cancer care, Dr. McAneny received a $19.8 million award from the Centers for Medicare & Medicaid Innovation (CMMI) to implement and test the COME HOME project, an oncology medical home model to help oncology practices provide higher quality cancer care at a lower cost.
A committed and experienced advocate for oncologists and oncology practices, Dr. McAneny has testified before Congress on issues ranging from the impact of insurance company mergers, Medicare changes, and repeal of the Sustainable Growth Rate (SGR). She has also represented the AMA in negotiations with health plans to reduce administrative burdens on physicians.
ASCO invites its members who are AMA members to reach out to their states’ AMA delegates and encourage them to vote for Dr. McAneny for president-elect in the June 2017 election.
For more information on Dr. McAneny and her positions on important healthcare policy issues, visit www.barbaramcaneny.com.